DKK1 and breast cancer: An up-regulation of DKK1 has already been described in the context of diverse malignant tumors such as breast cancer, lung cancer, myeloma or even esophageal cancer.[30]-[38] In these studies DKK1 was investigated in context of the tumor itself or as molecule potentially secreted by the tumor into patients' serum.